Far-reaching advances in the role of carbon nanotubes in cancer therapy
Graphical abstract
Introduction
Cancer includes a group of diseases involving unregulated cell growth with the potential to invade or expand to other parts of the body resulting in an estimate of 9.6 million deaths worldwide in 2018 [1]. Although numerous studies have been conducted to design new strategies for efficient cancer therapy, adjustment of cancer-related morbidity and mortality to an optimal level has not been achieved. The intrinsic shortcomings of conventional cancer treatment options such as surgical intervention, chemotherapy, and radiation therapy cause to rise the emergence of nanotechnology-based systems as a promising strategy for optimizing cancer therapy success by benefiting from the advantages and particular properties of nanoparticles for drug delivery, diagnosis, and imaging [2,3]. The unique properties such as high drug loading capacity and target site accumulation of nanomaterials such as liposomes, nanofibers, protein-based nanostructures, and inorganic nanoparticles introduced them as suitable carriers for overcoming biological barriers and pharmacokinetic obstacles like inadequate access of drugs to pathological sites, drug resistance at the cellular level, drug resistance at tumor microenvironment level, inefficient eradication of cancer stem cells and lack of specificity, in comparison to use of pristine anticancer drugs and traditional drug delivery systems [4,5].
Inorganic nanoparticles such as metal oxides, gold, and carbon-based nanomaterials, have gained increasing attention during the last decade as potential carriers for diagnostics and therapeutics of various cancers [[6], [7], [8], [9], [10], [11], [12], [13]]. Among inorganic nanoparticles, carbon nanotubes (CNTs) have been developed due to their exclusive physicochemical properties and high capability of binding to several materials including anticancer drugs, proteins, genes, etc. [14]. Single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) are the two types of CNTs with a broad range of features and functions have been extensively studied to explore the various perspectives of their application in cancer treatment. CNTs can be classified as mediators and nano-carriers for targeted cancer therapy [14]. In spite of expansive studies since their discovery, CNTs and their potential novel applications remain a hot topic for researchers in different disciplines. The aim of this study was to review the performance of SWCNTs and MWCNTs in cancer therapy either as a mediator or carrier, analyze the structure and mechanism of CNTs-based complex and their impact on several cancer cell lines both in-vitro and in vivo situation.
To review the effect of CNTs on cancer therapy, 8 main keywords including “carbon nanotubes”, “single-walled carbon nanotube”, “multi-walled carbon nanotubes”, “cancer treatment/therapy”, “cancer cell line” and “In vivo effect of CNTs on cancers” have been searched to found the relevant articles for 30 days. Over 500 articles were retrieved which were published from inception to June 2020. The search was narrowed to cover only the therapeutic effects of CNTs on cancers and the rest articles were removed from the references.
Section snippets
CNTs as a member of carbon nanomaterials family
Carbon-based nanomaterials are more becoming attractive day after day for biological application due to the essence of diverse carbon allotropes, such as amorphous carbon, graphite, diamonds, CNTs, graphene oxide, carbon quantum dots and fullerene. Each of the carbon-based nanostructures display unbeatable characteristics and has been largely exploited in multiple biomedical applications including drug delivery [15]. However, among several carbon-based nanomaterials, graphite and its
Biocompatibility of CNTs
CNTs are heterogeneous nanomaterials with diverse physicochemical properties that can promote the unfavorable biological and pharmacological effects. Therefore, the compatibility of CNTs with biological systems is an obstacle to the realization of their application for medical purposes. Several issues such as uncontrollable agglomeration of pristine CNTs, incompatibility with biological medium, potential adverse effects, immunogenicity, cellular toxicity, organ accumulation and biopersistence
Surface modification/functionalization of CNTs
CNTs tend to agglomerate uncontrollably due to van der Waals forces among bundles and high surface energy. This hinders their dispersion in almost all organic and inorganic solvents. The poor dispensability and insolubility of CNTs have limited their use in biomedical applications. Therefore, the efficient application of CNTs needs the significant chemical modifications for improving their compatibility with host materials [32]. Furthermore, there is a relationship between blood circulation
Protein corona of CNTs
Due to their high surface area, CNTs can interact with variety of biomolecules through charge complementary, π–π stacking or hydrophobic interactions to form a dynamic composition, when administered in vivo, the most common phenomenon is related to adsorption of proteins from plasma and/or intracellular fluid on the surface of these nanomaterials [48] either by diffusion, or by moving down a potential energy gradient to reduce their surface energy [49] which results in the formation of a layer,
Cellular toxicity of CNTs in normal and cancer cells
Although the cellular toxicity of CNTs are highly dependent of heterogeneity of cell lines used for in cytotoxicity assessment [68], they have demonstrated their ability to reduce the cell viability in both malignant cells [69] and normal cells through various mechanisms [60]. In general, prior studies have confirmed that CNTs could inhibit cell proliferation and promote cell death in several ways. Overall, CNTs can induce membrane destabilization, reduce cell adherence ability, derive
In vivo adverse effects of CNTs
CNTs induced adverse effects have been one of the major concerns of their usage in biomedical area. CNTs might fit the fiber pathogenicity pattern resembling other high aspect ratio fibrous nanomaterials particularly asbestos [98]. To boot, as previously mentioned, CNTs can demonstrate cytotoxicity effects on cells in different levels through various mechanisms depending on certain traits. Therefore they can cause harmful adverse events in the case of infecting the normal cells. Also, CNTs
Pharmacokinetics of CNTs
The bioactivity of any xenobiotic biological system depends on the rate and extent of their absorption, distribution, metabolism, and elimination (ADME). CNT-complexes are generally administered intravenously when used for cancer therapy leading to rapid delivery and distribution all through the vasculature. Therefore, systemic absorption of these nanomaterials is not a crucial matter in their biomedical application for cancer treatment. While, distribution of CNTs in biological environment
CNTs-based modalities in cancer treatments
The unique properties of CNTs such as high loading capacity and stability of CNTs in binding to various chemicals and biological molecules, large surface area, small size and efficient cellular internalization as well as their ability to be chemically and physically modified, have made them suitable candidates as delivery vehicles for therapeutic and diagnostic agents in various diseases, especially in cancer. Moreover, their strong optical absorption in the Near-Infrared (NIR) biological
Conclusion
In this review, we summarized the promises, facts and limitations of developing more efficacious treatment strategies for cancer based on single- and multi-walled carbon nanotubes. The great efforts have been invested by numerous researchers to explore the potential contributions of CNTs in cancer treatment. It has been clearly shown that there is notable potential for CNTs to enhance cancer therapy outcomes. The unique properties of CNTs such as their amendable physicochemical properties, high
Funding source
None.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References (234)
- et al.
Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement
Nano Today
(2018) - et al.
Fabrication of chitosan/poly (lactic acid)/graphene oxide/TiO2 composite nanofibrous scaffolds for sustained delivery of doxorubicin and treatment of lung cancer
Int. J. Biol. Macromol.
(2018) - et al.
A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide
Int. J. Biol. Macromol.
(2017) - et al.
UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid
Int. J. Biol. Macromol.
(2020) - et al.
Synthesis of magnetic gold coated poly (ε-caprolactonediol) based polyurethane/poly (N-isopropylacrylamide)-grafted-chitosan core-shell nanofibers for controlled release of paclitaxel and 5-FU
Int. J. Biol. Macromol.
(2020) - et al.
Incorporation of magnetic NaX zeolite/DOX into the PLA/chitosan nanofibers for sustained release of doxorubicin against carcinoma cells death in vitro
Int. J. Biol. Macromol.
(2019) - et al.
Doxorubicin hydrochloride-loaded electrospun chitosan/cobalt ferrite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release
Int. J. Biol. Macromol.
(2018) - et al.
Gold coated poly (ε-caprolactonediol) based polyurethane nanofibers for controlled release of temozolomide
Biomed. Pharmacother.
(2017) - et al.
Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds
Mater. Sci. Eng. C
(2015) - et al.
Biological interactions of carbon-based nanomaterials: from coronation to degradation
Nanomedicine
(2016)